Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (il-17) antagonists

作者: Hanno Richards , Brian Porter , Christian Mann

DOI:

关键词:

摘要: The present disclosure relates to methods for treating non-radiographic axial spondyloarthritis (nr-axSpA) patients and inhibiting the progression of structural damage in these patients, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses antibodies, such as secukinumab, nr-axSpA well medicaments, dosing regimens, pharmaceutical formulations, dosage forms, kits use methods.

参考文章(17)
Arndt Brachat, Stephan Bek, Yali Li, Ying Wang, Wolfgang Hueber, Roman Yelensky, Methods of treating ankylosing spondylitis using il-17 antagonists ,(2013)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Hanno Richards, Matthias Machacek, Shephard Mpofu, Karthinathan Thangavelu, Methods of treating rheumatoid arthritis using il-17 antagonists ,(2011)
Michael Cooreman, Padova Franco E. Di, Il-17 antagonistic antibodies fpr treating cancer ,(2007)
Leslie Goh, Ash Samanta, Update on biologic therapies in ankylosing spondylitis: a literature review International Journal of Rheumatic Diseases. ,vol. 15, pp. 445- 454 ,(2012) , 10.1111/J.1756-185X.2012.01765.X
Xenofon Baraliakos, Juergen Braun, Biologic Therapies for Spondyloarthritis: What Is New? Current Rheumatology Reports. ,vol. 14, pp. 422- 427 ,(2012) , 10.1007/S11926-012-0282-2
Denis Poddubnyy, Martin Rudwaleit, Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update. Expert Opinion on Biological Therapy. ,vol. 13, pp. 1599- 1611 ,(2013) , 10.1517/14712598.2013.839653
Pedro Machado, Robert Landewé, Désirée van der Heijde, New developments in the diagnosis and treatment of axial spondyloarthritis Clinical investigation. ,vol. 3, pp. 153- 171 ,(2013) , 10.4155/CLI.12.148
Jean-Michel Rene Rondeau, Hermann Gram, Margit Jeschke, Franco E. Di Padova, Hans Hofstetter, Wim Van Den Berg, IL-17 antagonistic antibodies ,(2005)
R Landewé, J Braun, A Deodhar, M Dougados, W P Maksymowych, P J Mease, J D Reveille, M Rudwaleit, D van der Heijde, C Stach, B Hoepken, A Fichtner, G Coteur, M de Longueville, J Sieper, Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study Annals of the Rheumatic Diseases. ,vol. 73, pp. 39- 47 ,(2014) , 10.1136/ANNRHEUMDIS-2013-204231